-
All Resources
(choose a category)
-
All Resources
-
selected
Evidence
Evidence, advice, guidance and standards
-
selected
Improvement
Improvement and implementation support
-
Scrutiny
Assurance, scrutiny, measurement and reporting
-
-
Healthcare Area
- Dermatology
- Musculoskeletal system
-
Resource Type
- NICE Guidance
- Programme
- Year
- Page 1 of 1
1 results found filtered by Evidence Remove Evidence Filter Improvement Remove Improvement Filter 2010 Remove 2010 Filter Dermatology Remove Dermatology Filter NICE Guidance Remove NICE Guidance Filter Clear Search
-
Appraisal Guidance No 180 – Ustekinumab for the treatment of adults withmoderate to severe psoriasis
- Published
- 24 February 2010
- Cycle of Improvement
- Evidence


